HAKAN BAYBORA

Dr. HAKAN BAYBORA


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2025 in Retina
Verified
Journal Article
Closed access
EOEce Md Ozal
Ece Md Ozal
MGMuzaffer Said Guler
Muzaffer Said Guler
MKMurat Md Karapapak
Murat Md Karapapak
HBHAKAN BAYBORA
HAKAN BAYBORA
SESerhat Ermis
Serhat Ermis
SOSadık Altan Assoc. Prof. Ozal
Sadık Altan Assoc. Prof. Ozal
Purpose: The aim of this study was to compare macular vessel density (VD) in eyes with macula-off rhegmatogenous retinal detachment after vitrectomy with gas or silicone oil (SO) tamponade. Methods: Patients with macula-off rhegmatogenous retinal detachment who underwent vitrectomy with either gas or SO tamponade were included. Best-corrected visual acuity (BCVA) and VD in superficial and deep retinal capillary plexuses (superficial capillary plexus and deep capillary plexus), choriocapillaris (choriocapillaris plexus), and foveal avascular zone were assessed using optical coherence tomography angiography. Comparisons were made with the unaffected fellow eye. Results: Fifty patients (average age: 57.9 ± 9.1 years) participated, with 26 eyes undergoing SO tamponade and 24 gas tamponade. No significant differences were found in baseline characteristics. Postoperative BCVA significantly improved in both groups. In the SO group, BCVA improved from 2.00 ± 0.77 logarithm of the minimum angle of resolution (20/2000 Snellen) to 0.95 ± 0.52 logarithm of the minimum angle of resolution (20/178 Snellen). In the gas tamponade group, BCVA improved from 2.12 ± 0.70 logarithm of the minimum angle of resolution (20/2636 Snellen) to 0.70 ± 0.55 logarithm of the minimum angle of resolution (20/100 Snellen) (P < 0.001 for both groups). Moreover, the gas tamponade group achieved significantly better postoperative BCVA compared with the SO group (P < 0.05). The silicone oil tamponade group exhibited significantly lower VD in superficial capillary plexus, deep capillary plexus, and choriocapillaris plexus quadrants (P < 0.05), while gas tamponade showed no significant differences. Conclusion: This study reveals a decrease in VD in superficial capillary plexus, deep capillary plexus, and choriocapillaris plexus induced by SO tamponade, suggesting potential toxic effects on macular perfusion. Gas tamponade resulted in superior BCVA outcomes and preserved VD. Further investigation into SO's underlying mechanisms and careful patient selection is warranted. Gas tamponade may offer better outcomes for macula-off rhegmatogenous retinal detachment.

22 January 2025 in International Ophthalmology
Verified
Journal Article
Closed access
PDF file
SHSerife Ciloglu Hayat
Serife Ciloglu Hayat
YYYusuf Cem Yilmaz
Yusuf Cem Yilmaz
SESerhat Ermis
Serhat Ermis
EOEce Ozal
Ece Ozal
MKMurat Karapapak
Murat Karapapak
SOSadık Altan Ozal
Sadık Altan Ozal

2 March 2024 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Open access
HBHAKAN BAYBORA
HAKAN BAYBORA
Objective: There has been some concern that anti -vascular growth factor treatment accelerates the development of macular atrophy in eyes with neovascular age -related macular degeneration. During the treatment with aflibercept, the thickness of choroid may decrease. This may lead to photoreceptor death. The rod cells are more susceptible to atrophic changes than cones during the disease. We aimed to find any thickness changes in the perifoveal outer nuclear layer, where the highest density of rods is found, during the aflibercept intravitreal injection therapy. Materials and Methods: Retrospectively, forty-two patients who were treated for age -related macular degeneration with choroidal neovascularization were included in the study. After the first three loading doses, intravitreal injections were repeated every two months. Outer nuclear layer thicknesses were measured 2000 mu m away from the center of the fovea with OCT, at a total of 20 points, located at 180 and 90 (degrees). The mean of these measurements was obtained before the treatment and 1 year after the therapy. Results were compared by using the Wilcoxon Rank Test. Results: The mean visual acuity was 1,11 +/- 0,287 logMAR at the beginning and increased to 0,53 +/- 0,32 LogMAR after. Perifoveal thickness was significantly reduced when compared with the thickness before the treatment ( p = 0.039, p < 0.05). This result was also significantly lower than the control group thicknesses ( p = 0.035, p < 0.05). Conclusion: Anti-VEGFs can cause loss of phagocytic functions of RPE. The mechanism of the observed thinning of the ONL may be described as follows: VEGF emitted by the RPE normally helps to maintain the choriocapillaris. Thus, injecting an anti-VEGF intravitreally causes RPE atrophy, which leads to a decrease in the choroidal vascular index. This in turn causes first the rods, and later the cones, that are part of the outer nuclear layer, to start to die and disappear, hence the thinning of this layer. As aflibercept consists of parts of the extracellular domain of both the VEGFR1 and VEGFR2 receptors, that are held together by a human IgG1 backbone, this makes the binding of aflibercept to VEGF-A and VEGF-B stronger as compared to the binding of the previously used ranibizumab or bevacizumab (by nearly a factor 100 in the case of the most abundant isoform VEGF-A 165). Besides, aflibercept also binds very well to placental growth factor (PIGF), which is also associated with several ocular diseases.

30 August 2024 in Current Eye Research
Verified
Journal Article
Closed access
SOSadık Altan Ozal
Sadık Altan Ozal
MKMurat Karapapak
Murat Karapapak
EOEce Ozal
Ece Ozal
SESerhat Ermis
Serhat Ermis
SGSerkan Güler
Serkan Güler
YYYusuf Cem Yılmaz
Yusuf Cem Yılmaz
Purpose: This study aimed to assess and compare the retinal toxicity associated with silicone oil (SO) and perfluoropropane (C3F8) tamponade following vitreoretinal surgery for fresh rhegmatogenous retinal detachment (RRD), utilizing the office-based Diopsys (R) NOVA (TM) system for evaluation. Methods: Patients who underwent vitreoretinal surgery for fresh RRD and had SO (group 1) or C3F8 (group 2) tamponade were included in a prospective analysis. Flicker full field electroretinography (ffERG) and pattern electroretinography (PERG) tests were performed at 6 months postoperatively. Results: Postoperative best corrected visual acuity (logMAR) was significantly different in group 1 and group 2 patients, 0.48 +/- 0.3 and 0.30 +/- 0.2, respectively. No significant disparities were found in demographic variables. Flicker ffERG and PERG recordings revealed notable alterations in retinal function parameters in the group 1 compared to the group 2. Conclusion: Our findings suggest a correlation between SO tamponade and retinal dysfunction, evidenced by office-based ERG measurements. The Diopsys (R) NOVA (TM) protocol offers clinical ease in assessing retinal function. Further controlled studies are essential to validate these findings and guide clinical practice effectively.

1 January 2019 in Beyoglu Eye Journal
Verified
Journal Article
Open access
HBHAKAN BAYBORA
HAKAN BAYBORA
Chronic dacryocystitis is usually seen in middle-aged or older women, suggesting that decreased estrogen and progesterone serum levels may be a causative factor in the disease pathology. However, the occurrence of the disease in premenopausal females and males suggests that there may be more to the explanation than the level of female sex hormones. The purpose of the present study was to investigate estrogen and progesterone receptor positivity in the lacrimal sacs of individuals with and without chronic dacryocystitis. The study group included 50 female and 20 male patients diagnosed with chronic dacryocystitis. Lacrimal sac samples were taken during a dacryocystorhinostomy. The control group comprised 29 cadavers with no evidence of lacrimal system pathology in the health records. The samples were obtained transconjunctivally. Lacrimal sac samples from both groups were stained with the estrogen and progesterone receptor protein antigen. Fisher’s exact test and a chi-square test were used to compare the receptor positivity results of premenopausal and postmenopausal women, and samples of those with dacryocystitis and cadaver sacs without the disease. In the control group, estrogen receptor positivity was observed in the samples of 2 premenopausal females. In the study group, estrogen receptor positivity was seen in 4 premenopausal females. There was no significant difference in estrogen receptor positivity between the premenopausal and postmenopausal female groups (p=0.41). A similar result was not established between the premenopausal and postmenopausal females in case group (p=0.056). No comparison was made of the progesterone receptor because only 1 example of progesterone receptor positivity was found in a premenopausal female in the dacryocystitis group. Estrogen receptor positivity did not seem to be a factor in chronic dacryocystitis physiopathology.

19 May 2026 in BMC Ophthalmology
Verified
Journal Article
Open access
HBHAKAN BAYBORA
HAKAN BAYBORA
EÖEce Özal
Ece Özal
SÖSadık Altan Özal
Sadık Altan Özal
There are research findings suggesting that antiglaucoma agents may reduce aqueous humor outflow and decrease the elimination of intravitreally administered anti-vascular endothelial growth factor agents, prolonging their effect. The aim of this study was to evaluate central macular thickness (CMT) after repeated injections, using real-world data, to provide insight into how this phenomenon may affect clinical outcomes. One hundred forty-seven patients with diabetic macular edema (DME) were included in the study;66 patients received topical therapy due to pre-existing glaucoma, either primary open- angle or pseudoexfoliative glaucoma, and 81 patients without glaucoma. CMT values were evaluated before treatment, 1 month after the first three injections, 1 month after the subsequent four injections, and at the end of the first year. No significant differences were detected with respect to HbA1c levels, the presence of SRF, or prior photocoagulation (p = 0.085, p = 0.24, and p = 0.3, respectively). There was no difference between anti-glaucoma agent users and control group in CMT measurements 1 month after the first three injections (p = 0.6, p > 0.05). However, measurements taken 1 month after the subsequent four injections were significantly lower in patients using topical anti-glaucoma agents (p = 0.001, p < 0.05). At the 1-year measurement interval, although the values remained lower, the significant difference had disappeared (p = 0.11, p > 0.05). The presence of hyper reflective dots (HRD) was also greater in this group (p = 0.021, p < 0.05). At the 1-year measurement interval, although the values remained lower, the significant difference had disappeared (p = 0.11, p > 0.05). The presence of HRD and the combined presence of SRF and HRD had a significant effect on the changes in the measurements (F (4.412), p = 0.006, Eta2 = 0.103 and F (4.51), p = 0.001, Eta2 = 0.106, respectively). Although the use of topical anti-glaucoma therapy may have a partial effect on reduction of CMT in DME patients receiving anti-vascular endothelial growth factor (anti-VEGF) treatment.